7-150293323-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001164458.2(ACTR3C):​c.142G>A​(p.Val48Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000151 in 1,586,280 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

ACTR3C
NM_001164458.2 missense

Scores

2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.30

Publications

0 publications found
Variant links:
Genes affected
ACTR3C (HGNC:37282): (actin related protein 3C) Predicted to enable ATP binding activity. Predicted to contribute to actin filament binding activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.05090311).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACTR3CNM_001164458.2 linkc.142G>A p.Val48Ile missense_variant Exon 3 of 8 ENST00000683684.1 NP_001157930.1 Q9C0K3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACTR3CENST00000683684.1 linkc.142G>A p.Val48Ile missense_variant Exon 3 of 8 NM_001164458.2 ENSP00000507618.1 Q9C0K3-1

Frequencies

GnomAD3 genomes
AF:
0.0000462
AC:
7
AN:
151454
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000730
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000193
AC:
4
AN:
206904
AF XY:
0.0000273
show subpopulations
Gnomad AFR exome
AF:
0.000154
Gnomad AMR exome
AF:
0.0000661
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000118
AC:
17
AN:
1434826
Hom.:
0
Cov.:
33
AF XY:
0.00000985
AC XY:
7
AN XY:
710788
show subpopulations
African (AFR)
AF:
0.000211
AC:
7
AN:
33168
American (AMR)
AF:
0.000168
AC:
7
AN:
41616
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25594
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39140
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82376
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51748
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5732
European-Non Finnish (NFE)
AF:
0.00000274
AC:
3
AN:
1096072
Other (OTH)
AF:
0.00
AC:
0
AN:
59380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000462
AC:
7
AN:
151454
Hom.:
0
Cov.:
31
AF XY:
0.0000541
AC XY:
4
AN XY:
73884
show subpopulations
African (AFR)
AF:
0.0000730
AC:
3
AN:
41102
American (AMR)
AF:
0.000197
AC:
3
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10442
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67960
Other (OTH)
AF:
0.00
AC:
0
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.0000248
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 08, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.142G>A (p.V48I) alteration is located in exon 3 (coding exon 2) of the ACTR3C gene. This alteration results from a G to A substitution at nucleotide position 142, causing the valine (V) at amino acid position 48 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
21
DANN
Benign
0.94
DEOGEN2
Benign
0.24
T;.;.;.
Eigen
Benign
-0.53
Eigen_PC
Benign
-0.49
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.88
D;D;D;T
M_CAP
Benign
0.0016
T
MetaRNN
Benign
0.051
T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.64
N;.;.;.
PhyloP100
5.3
PROVEAN
Benign
-0.53
N;N;N;N
REVEL
Benign
0.14
Sift
Benign
0.33
T;T;T;T
Sift4G
Benign
0.53
T;T;.;T
Polyphen
0.0040
B;.;.;.
Vest4
0.25
MutPred
0.51
Loss of glycosylation at T46 (P = 0.1195);Loss of glycosylation at T46 (P = 0.1195);.;Loss of glycosylation at T46 (P = 0.1195);
MVP
0.13
MPC
1.6
ClinPred
0.16
T
GERP RS
0.80
Varity_R
0.028
gMVP
0.32
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs779932137; hg19: chr7-149990412; API